Bandaram Pharma Statements
52
Data from Bandaram Pharma`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
INR - Indian rupee
Last reporting period:
31 Mar, 2023
Next reporting period:
27 Sep, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
09 Aug, 2024
Bandaram Pharma Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
154.58
552.8 %
100
134.95
92.8
19.63
272.6 %
7.2
—
0
3.194
1.8
9.417
37.9 %
2.8
10.213
753.8 %
4.4
-2.744
-1.3
—
0
7.469
393.6 %
3.1
0.681
0.7
5.63
321.3 %
1.3
0.653
8.623
23.678
—
100
18.41
77.8
5.268
—
22.2
—
0
2.43
10.3
6.83
—
28.8
-1.562
—
-6.6
-0.982
-4.1
—
0
-2.544
—
-10.7
—
0
-2.544
—
-10.7
-0.295
8.623